Furthermore, these tumors exhibit shared transcriptomic and phenotypic features with aggressive SMARCA4-deficient malignancies occurring at other sites, including SSCOHT and malignant rhabdoid tumor. This evidence concerns the gene SMARCA4 and rhabdoid tumor.